Carrie Jones
-
Vanderbilt CTTC honors five pioneering faculty as newly inducted Master Innovators
The Center for Technology Transfer and Commercialization has honored five faculty members as 2024 Master Innovators for their groundbreaking research and transformative innovations. These pioneers, recognized for achievements spanning patents, startups and impactful technologies, exemplify Vanderbilt's dedication to translating academic excellence into societal advancements. Read MoreDec 5, 2024
-
Faculty honored for teaching, mentoring at Spring Assembly
Chancellor Daniel Diermeier and Faculty Senate Chair Andrea Capizzi presented awards to 10 faculty members who made a significant impact through scholarship, research, creative expression, service, teaching or mentoring during the April 11 Spring Faculty Assembly. Read MoreApr 15, 2024
-
Vanderbilt Center for Addiction Research joins Discovery Vanderbilt; Calipari appointed director
The Vanderbilt Center for Addiction Research, led by Erin Calipari, advances research to understand how addiction and substance use disorder develops in the brain. VCAR’s goals are to develop new pharmaceutical strategies and to destigmatize addiction as a personal failing. Read MoreDec 14, 2023
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials. Read MoreDec 4, 2023
-
Putting schizophrenia to bed
A new compound developed at Vanderbilt treats multiple symptoms of schizophrenia in an animal model, without causing sedation. Read MoreMar 21, 2016
-
Drug-like molecules aimed at improving treatment of Parkinson’s
Drug-like molecules described by Vanderbilt researchers could lead to Parkinson's treatments with fewer side effects. Read MoreSep 30, 2011
-
New drug-like molecules could improve schizophrenia treatment
The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia. Read MoreSep 22, 2011
-
Milestone in development of new treatment for ‘fragile X’
Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism. Read MoreSep 15, 2011
-
Neuroscience drug discovery center opens at Vanderbilt
Vanderbilt University Medical Center has established a new Center for Neuroscience Drug Discovery to accelerate research that may lead to new treatments for Parkinson's disease, schizophrenia and other disorders of the brain. Read MoreMar 11, 2011
-
Pain from the Past: A conversation with a psychiatrist and a scientist about post traumatic stress disorder
Watch video of Dr. Paul W. Ragan, associate professor of psychiatry, and Carrie Jones, assistant professor of pharmacology, speaking March 3. Post Traumatic Stress Disorder, or PTSD, is a severe anxiety disorder that occurs in people who have experienced physical or psychological trauma. Triggering events can include experiences like military combat, car accidents,… Read MoreMar 9, 2011
-
Brainstorm 2011 events begin March 3
"Brainstorm 2011," a series of free public events about brain research hosted by Vanderbilt University, will explore post-traumatic stress disorder, depression and the mysteries of feelings and perception throughout the month of March. Read MoreFeb 23, 2011